Enabling Technologies

Identification and characterization of functional perturbants (antibody, siRNA, peptide, small molecule).

Model organism sequence data. Extensive collection of gene expression data. Genetic markers of drug metabolism and efficacy.

Single cell analysis and sorting of cells in suspension.

DNA sequencing (standard long reads: 500-750bp or Nextgen: 18-150bp), microarrays, qPCR)

Enabling Technology Cores Supporting Genomics at Stanford.

From site-licensed software for basic research to massively-parallel computing power to handling clinical research data.

MRI, CT, PET, SPECT, luminescence and fluorescence whole animal imaging, ultrasound, live animal and tissue-slice two-photon confocal microscopy, inverted microscope confocal imaging, deconvolution widefield microscopy, SEM, TEM.

Including nanofabrication of reagents and devices for biomedical research.

Animal models of human behavior, including disease models, and human behavioral testing.

Biomedical research supplies, photography and graphic arts, and a machine shop.

Resources for supplying and analyzing anonymized patient samples.

High throughput screening, compound formulation, and pharmacokinetic analysis.

Analysis of tissue samples, QC of purified proteins.

Resources for the determination of three dimensional protein structures.

Animal husbandry and veterinary care. Generation of animal models. Testing the effect of perturbants and/or genetic changes in behavioural, disease, and pharmacological models.